RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to TOP2A

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
DOXORUBICIN	Small molecule	Ewing sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Ovarian Embryonal Carcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	adult T acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Richter syndrome	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
AMRUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lung adenocarcinoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
AMSACRINE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	4.0	-	ATC
DOXORUBICIN	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
BERUBICIN HYDROCHLORIDE	Small molecule	glioma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Thymic Carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	core binding factor acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	mesothelioma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	optic nerve glioblastoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	salivary gland adenoid cystic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	T-cell non-Hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	childhood acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	alveolar soft part sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ALDOXORUBICIN	Small molecule	metastatic colorectal cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	pilocytic astrocytoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	post-transplant lymphoproliferative disease	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	germ cell tumor	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
DAUNORUBICIN	Small molecule	myeloproliferative disorder	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Testicular Yolk Sac Tumor	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	adrenal cortex carcinoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	leiomyosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	epithelioid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	primary systemic amyloidosis	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Enrolling by invitation	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	bladder transitional cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	optic nerve glioblastoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic colorectal cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	precursor T-cell lymphoblastic leukemia-lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	urethra cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	graft versus host disease	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	leiomyosarcoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	renal cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
VALRUBICIN	Small molecule	in situ carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute erythroleukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	Abnormality of cardiovascular system morphology	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	extragonadal germ cell tumor	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	cancer	DNA topoisomerase II inhibitor	1.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	4.0	-	ATC
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastasis	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	extragonadal germ cell tumor	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ALDOXORUBICIN	Small molecule	chordoma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	malignant glioma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	carcinosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hemangiopericytoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
IDARUBICIN HYDROCHLORIDE	Small molecule	central nervous system non-hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ALDOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloblastic leukemia without maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	myeloproliferative disorder	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hepatoblastoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ALDOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	core binding factor acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	gastric cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	epithelioid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	mesothelioma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	0.5	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	angiosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	autoimmune thrombocytopenic purpura	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	retinoblastoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMSACRINE	Small molecule	leukemia	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	blastic plasmacytoid dendritic cell neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial endometrioid adenocarcinoma, variant with squamous differentiation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	neuroendocrine carcinoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
GANCOTAMAB	Antibody	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
TENIPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	post-transplant lymphoproliferative disease	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	oligoastrocytoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	Fallopian Tube Carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood germ cell tumor	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hepatoblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	angioimmunoblastic T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute megakaryoblastic leukaemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	heart failure	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	adrenal cortex carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
GANCOTAMAB	Antibody	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	relapsing-remitting multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	toxicity	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hepatoblastoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Splenic Marginal Zone Lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	malignant germ cell tumor of ovary	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
VOSAROXIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	4.0	-	ATC,DailyMed
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	refractory anemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	primitive neuroectodermal tumor	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	adult T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	germ cell tumor	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	chronic myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	chronic myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	dermatofibrosarcoma protuberans	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
VOSAROXIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adrenal gland pheochromocytoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	childhood acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Ewing sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urethra cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	metastatic prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature T-cells or NK-cells	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	adrenal cortex carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	T-cell non-Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	refractory anemia with ringed sideroblasts	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	precursor T-cell lymphoblastic leukemia-lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	soft tissue sarcoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Wilms tumor	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
AMSACRINE	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	3.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	AIDS	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Endometrial Serous Adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Fallopian Tube Carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	cervical cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	uterine sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	triple-negative breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	toxicity	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
IDARUBICIN	Small molecule	acute myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	0.5	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	HER2 Positive Breast Carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	prostate cancer	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
AMRUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	B-cell neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
AMRUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloblastic leukemia with maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	colorectal carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
AMRUBICIN HYDROCHLORIDE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Enrolling by invitation	ClinicalTrials
ETOPOSIDE	Small molecule	childhood acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	germ cell tumor	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	pancreatic carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	Ewing sarcoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Enrolling by invitation	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	mesenchymoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	gastric cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	seminoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
ETOPOSIDE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
VALRUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	4.0	-	ATC
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	Cutaneous T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	myeloid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
VOSAROXIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DEXRAZOXANE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	plasma cell leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	myelodysplastic/myeloproliferative disease	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ALDOXORUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	childhood acute myeloid leukemia with maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	undifferentiated high grade pleomorphic sarcoma of bone	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	carcinoma of liver and intrahepatic biliary tract	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	embryonal rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	gliosarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neuroendocrine carcinoma	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	basal cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
BERUBICIN	Small molecule	glioma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
AMRUBICIN	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	refractory anemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	adult T-cell leukemia/lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
IDARUBICIN	Small molecule	childhood acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	heart failure	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	refractory anemia with excess blasts	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	prostate cancer	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	Ewing sarcoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMRUBICIN	Small molecule	Thymoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMSACRINE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	4.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute basophilic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	glioma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Kidney Medullary Carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneal neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
AMSACRINE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	angioimmunoblastic T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	small cell carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
MITOXANTRONE	Small molecule	prolymphocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	ganglioneuroblastoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Desmoid-type fibromatosis	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	follicular lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	angiosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	choroid plexus neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
TENIPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	malignant peripheral nerve sheath tumor	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	Abnormality of cardiovascular system morphology	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	hemophagocytic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myeloid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	malignant epithelial tumor of ovary	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	soft tissue sarcoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma in situ	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	0.5	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast ductal carcinoma in situ	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
VOSAROXIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	carcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	brain neoplasm	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	pain	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
BECATECARIN	Small molecule	colorectal carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	extraosseous osteosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	kidney Wilms tumor	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of oropharynx	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	glioblastoma multiforme	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	refractory anemia with excess blasts	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	cardiomyopathy	DNA topoisomerase II inhibitor	4.0	-	DailyMed
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	0.5	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
BECATECARIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	0.5	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	endometrial adenosquamous carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	gastric cancer	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
VOSAROXIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
TENIPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	refractory anemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoid leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	toxicity	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	0.5	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	Sinonasal Undifferentiated Carcinoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	chronic myelomonocytic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	ganglioneuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ganglioneuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	fallopian tube cancer	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoid leukemia	DNA topoisomerase II inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Endometrial Serous Adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adrenal cortex carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	digestive system neuroendocrine tumor, grade 1/2	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	3.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	myeloproliferative disorder	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
AMRUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	soft tissue sarcoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Wilms tumor	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	extraskeletal myxoid chondrosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leiomyosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	dedifferentiated liposarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	refractory anemia	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	ependymoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	uterine leiomyosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neutropenia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	prostate cancer	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	childhood acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	4.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	toxicity	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urethra cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	triple-negative breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	cancer	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	3.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute erythroleukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloblastic leukemia without maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	mediastinal cancer	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	gliosarcoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neuroepithelial neoplasm	DNA topoisomerase II inhibitor	0.5	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	Ewing sarcoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	Ewing sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic oligoastrocytoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Testicular Choriocarcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Abnormality of blood and blood-forming tissues	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	acute leukemia of ambiguous lineage	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lung adenocarcinoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	chronic hepatitis B virus infection	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	undifferentiated high grade pleomorphic sarcoma of bone	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	Castleman disease	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neuromyelitis optica	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
BECATECARIN	Small molecule	male breast carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	pancreatic adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Thymoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prolymphocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	testicular carcinoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	colorectal carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	alveolar rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
AMRUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	follicular lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	glioblastoma multiforme	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	chronic myeloproliferative disorder	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	refractory anemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	4.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	4.0	-	ATC
DOXORUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Endometrial Clear Cell Adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	gastric cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Ewing sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	metastatic prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	carcinoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
ALDOXORUBICIN	Small molecule	pancreatic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	plasma cell leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	uterine leiomyosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	central nervous system cancer	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ALDOXORUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	uterine neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	peritoneal neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	acute erythroblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	follicular lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic oligodendroglioma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Merkel cell skin cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Richter syndrome	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	thyroid cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	0.5	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
TENIPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	childhood acute myeloid leukemia with maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood acute myeloid leukemia with maturation	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	colorectal carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	peritoneum cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	kidney cancer	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic melanoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	Granulocytic Sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
BECATECARIN	Small molecule	biliary tract cancer	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	teratoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	bone sarcoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	Ewing sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ALDOXORUBICIN	Small molecule	squamous cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	basal cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	0.5	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	angiosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	myeloproliferative disorder	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ALDOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	refractory anemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Malignant Bone Neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Sinonasal Undifferentiated Carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	adult T-cell leukemia/lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
BERUBICIN HYDROCHLORIDE	Small molecule	malignant glioma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	mesothelioma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	salivary gland adenoid cystic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute megakaryoblastic leukaemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute basophilic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	refractory anemia with excess blasts	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	retinoblastoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMRUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	hemophagocytic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	kidney Wilms tumor	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	adenosquamous lung carcinoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	leiomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	renal cell carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ganglioneuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	leiomyosarcoma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
DEXRAZOXANE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ALDOXORUBICIN	Small molecule	pancreatic carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	toxicity	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	Richter syndrome	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
AMRUBICIN	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	testicular neoplasm	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	histiocytoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	multiple sclerosis	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	4.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
BECATECARIN	Small molecule	kidney cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood ependymoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Wilms tumor	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	epithelioid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	ganglioneuroblastoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
BERUBICIN	Small molecule	glioblastoma multiforme	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	AIDS	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	T-cell non-Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	Ewing sarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
VOSAROXIN	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	gastric adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	human herpesvirus 8 infection	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	histiocytoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Lymphoma, AIDS-Related	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	B-cell neoplasm	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	leiomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	pancreatic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute erythroleukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	chronic myeloproliferative disorder	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	oligodendroglioma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	synovial sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	uterine neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Testicular Embryonal Carcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	small cell carcinoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ganglioneuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
TENIPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	urethra cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	nodal marginal zone B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	polycythemia vera	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoid leukemia	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	soft tissue sarcoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	gastric cancer	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	seminoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
AMSACRINE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	embryonal rhabdomyosarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	adult T-cell leukemia/lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic/myeloproliferative disease	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	central nervous system cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	glioblastoma multiforme	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	lung adenocarcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMRUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	malignant epithelial tumor of ovary	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	mesothelioma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	refractory anemia with excess blasts	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	liposarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMRUBICIN HYDROCHLORIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	AIDS	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
BECATECARIN	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	central nervous system non-hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lung neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DEXRAZOXANE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
AMRUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Ovarian Yolk Sac Tumor	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	thymus neoplasm	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hemangiopericytoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	myelodysplastic/myeloproliferative disease	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
VOSAROXIN	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute basophilic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	refractory anemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myeloproliferative disorder	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Merkel cell skin cancer	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	pediatric fibrosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	malignant peripheral nerve sheath tumor	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	0.5	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	oligoastrocytoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	squamous cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute megakaryoblastic leukaemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	testicular neoplasm	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	atypical teratoid rhabdoid tumor	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small intestine cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
AMRUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	3.0	-	ATC
DAUNORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	squamous cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	HIV-1 infection	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	MALT lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
VOSAROXIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	mesothelioma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloblastic leukemia without maturation	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	testicular neoplasm	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	gastric carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	kidney cancer	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
MITOXANTRONE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
VOSAROXIN	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	anaplastic astrocytoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute megakaryoblastic leukaemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
VALRUBICIN	Small molecule	bladder transitional cell carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	Central Nervous System Lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Nausea and vomiting	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Richter syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	ganglioneuroblastoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	uterine neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	primitive neuroectodermal tumor	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	chronic inflammatory demyelinating polyneuropathy	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Fallopian Tube Carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	Hepatoblastoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	mesothelioma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	myeloproliferative disorder	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II inhibitor	4.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	0.5	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	brain neoplasm	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	peritoneum cancer	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	prostate cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell non-Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	large cell neuroendocrine carcinoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	4.0	-	ATC,DailyMed
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	autoimmune thrombocytopenic purpura	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	neuroendocrine neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
VOSAROXIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
VOSAROXIN	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	adrenal cortex carcinoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	COVID-19	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	Hereditary breast and ovarian cancer syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
VOSAROXIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	triple-negative breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Thyroid Gland Undifferentiated (Anaplastic) Carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	adult T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	triple-negative breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	core binding factor acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	neutropenia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	dermatofibrosarcoma protuberans	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	refractory anemia with ringed sideroblasts	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	secondary progressive multiple sclerosis	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN CITRATE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
BECATECARIN	Small molecule	lung cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
AMRUBICIN HYDROCHLORIDE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute leukemia of ambiguous lineage	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	kidney cancer	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	extraosseous osteosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	childhood kidney neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian sex cord-stromal tumor	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute leukemia of ambiguous lineage	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	retinoblastoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	myelofibrosis	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	retinoblastoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	central nervous system non-hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	angioimmunoblastic T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	pancreatic carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	relapsing-remitting multiple sclerosis	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Myasthenia gravis	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DAUNORUBICIN CITRATE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	synovial sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	plasma cell leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
AMRUBICIN	Small molecule	Thymic Carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Thymoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoplasmacytic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hemophagocytic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Suspended	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	nasopharyngeal neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	colorectal cancer	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	4.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute graft vs. host disease	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute leukemia of ambiguous lineage	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
BERUBICIN HYDROCHLORIDE	Small molecule	carcinoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Kidney Medullary Carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	childhood acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	kidney cancer	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	4.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
PAZUFLOXACIN	Small molecule	bacterial disease	DNA topoisomerase II inhibitor	3.0	-	ATC
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Lymphoma, AIDS-Related	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	gastric cancer	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	0.5	Active, not recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	neuromyelitis optica	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Endometrial Clear Cell Adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neutropenia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	alveolar soft part sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hepatoblastoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neutropenia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
VOSAROXIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DEXRAZOXANE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	salivary gland cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	choroid plexus neoplasm	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	gestational trophoblastic neoplasm	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	chronic lymphocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	cutaneous melanoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Enrolling by invitation	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
TENIPOSIDE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	4.0	-	ATC
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urethra cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	malignant glioma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute monocytic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
TENIPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	relapsing-remitting multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	squamous cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoid neoplasm	DNA topoisomerase II inhibitor	4.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Endometrial Clear Cell Adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	teratoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
TENIPOSIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	4.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	ganglioneuroblastoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	colorectal cancer	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	brain cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	germ cell tumor	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	metastasis	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Thyroid Gland Undifferentiated (Anaplastic) Carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	metastasis	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	myeloid sarcoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneal neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	esophageal cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	embryonal rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	neuromyelitis optica	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	undifferentiated high grade pleomorphic sarcoma of bone	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloblastic leukemia with maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	bone sarcoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	malignant pleural mesothelioma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	myeloid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast carcinoma in situ	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	refractory anemia with ringed sideroblasts	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	bladder transitional cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Richter syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Ewing sarcoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Endometrial Serous Adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Wilms tumor	DNA topoisomerase II alpha inhibitor	4.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	cholangiocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
VALRUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	malignant epithelial tumor of ovary	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	alveolar rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN CITRATE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liposarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	anaplastic oligoastrocytoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
IDARUBICIN	Small molecule	refractory anemia with ringed sideroblasts	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Endometrial Clear Cell Adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Ovarian Germ Cell Tumor	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	cancer	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	0.5	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	pain	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Opsoclonus-Myoclonus Syndrome	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Lymphoma, AIDS-Related	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	neuroendocrine carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ALDOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	Castleman disease	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	follicular lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
VALRUBICIN	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	Kaposi's sarcoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	brain cancer	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Castleman disease	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic ependymoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	gastric cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	childhood kidney neoplasm	DNA topoisomerase II inhibitor	3.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
BERUBICIN HYDROCHLORIDE	Small molecule	glioblastoma multiforme	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
ALDOXORUBICIN	Small molecule	glioblastoma multiforme	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
MITOXANTRONE HYDROCHLORIDE	Small molecule	toxicity	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute leukemia of ambiguous lineage	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
VOSAROXIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	adrenal gland pheochromocytoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMSACRINE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	nongerminomatous germ cell tumor	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute monocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	oligodendroglioma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
TENIPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
ETOPOSIDE	Small molecule	medulloblastoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloblastic leukemia with maturation	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
PAZUFLOXACIN	Small molecule	bacterial conjunctivitis	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	childhood acute myeloid leukemia with maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood germ cell tumor	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DEXRAZOXANE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	secondary progressive multiple sclerosis	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
BECATECARIN	Small molecule	small intestine cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	NUT midline carcinoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	cutaneous squamous cell carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	gastric cancer	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	Ewing sarcoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
BERUBICIN	Small molecule	glioblastoma multiforme	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	mesenchymoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	adult T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN HYDROCHLORIDE	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	central nervous system non-hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	central nervous system non-hodgkin lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	epithelioid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute erythroleukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
IDARUBICIN	Small molecule	chronic myeloproliferative disorder	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
VOSAROXIN	Small molecule	neoplasm	DNA topoisomerase II inhibitor	3.0	-	ATC
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	uterine neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	cancer	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	esophageal cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	nongerminomatous germ cell tumor	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	breast neoplasm	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	plasma cell leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	Granulocytic Sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	primary peritoneal carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Burkitts lymphoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	adrenal cortex carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Waldenstrom macroglobulinemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Endometrial Serous Adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	mature T-cell and NK-cell non-Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ALDOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	adenoid cystic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
VOSAROXIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	triple-negative breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Suspended	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	HER2 Positive Breast Carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	retinoblastoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	central nervous system nongerminomatous germ cell tumor	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Suspended	ClinicalTrials
DOXORUBICIN	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	0.5	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	prostate carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	primitive neuroectodermal tumor	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Stiff-Person syndrome	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	Lymphoma, AIDS-Related	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ALDOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	B-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	-	FDA
DOXORUBICIN	Small molecule	Burkitts lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Kaposi's sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	myeloid sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	adult acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	cervical cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	post-transplant lymphoproliferative disease	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	alveolar rhabdomyosarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	chronic myelogenous leukemia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DAUNORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	4.0	-	ATC
ALDOXORUBICIN	Small molecule	pancreatic ductal adenocarcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	anaplastic large cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	neuroendocrine carcinoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	fallopian tube cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
BERUBICIN	Small molecule	carcinoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	urothelial carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	childhood B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	colorectal carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	pancreatic ductal adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ALDOXORUBICIN	Small molecule	pancreatic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	unspecified peripheral T-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	lymphoma	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	follicular lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	osteosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	sarcoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial adenosquamous carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
AMRUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	Richter syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Hodgkins lymphoma	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	acute myeloblastic leukemia without maturation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	Lymphoma, AIDS-Related	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Abnormality of blood and blood-forming tissues	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	cervical cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	neuromyelitis optica	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
PAZUFLOXACIN	Small molecule	Otitis media	DNA topoisomerase II inhibitor	1.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	myelosuppression	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	prostate cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	lung cancer	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	mixed phenotype acute leukemia	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	hepatocellular carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
MITOXANTRONE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	4.0	-	ATC
MITOXANTRONE	Small molecule	pancreatic carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	male breast carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	pediatric fibrosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
VALRUBICIN	Small molecule	in situ carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	germ cell tumor	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
AMSACRINE	Small molecule	leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	renal cell carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	pancreatic endocrine carcinoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	extragonadal germ cell tumor	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	high grade B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast adenocarcinoma	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
BECATECARIN	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	brain neoplasm	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	childhood acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood ependymoma	DNA topoisomerase II inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	multiple sclerosis	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
MITOXANTRONE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	rhabdomyosarcoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	adult acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DAUNORUBICIN	Small molecule	adult B acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	cancer	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	ovarian cancer	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	pilocytic astrocytoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Active, not recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	mouth neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	Mantle cell lymphoma	DNA topoisomerase II alpha inhibitor	4.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	adult acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
DAUNORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	essential thrombocythemia	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ALDOXORUBICIN	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	testicular neoplasm	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	nodular sclerosis Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	Central Nervous System Neoplasm	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	childhood T acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
ALDOXORUBICIN	Small molecule	soft tissue sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	Richter syndrome	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	testicular carcinoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	breast cancer	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	neoplasm of mature B-cells	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	angioimmunoblastic T-cell lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
BECATECARIN	Small molecule	lymphoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	neuroblastoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
AMRUBICIN	Small molecule	small cell lung carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	brain neoplasm	DNA topoisomerase II inhibitor	0.5	Recruiting	ClinicalTrials
VALRUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	Richter syndrome	DNA topoisomerase II inhibitor	2.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Wilms tumor	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	T-cell acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DEXRAZOXANE	Small molecule	neoplasm	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	osteosarcoma	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	anaplastic oligodendroglioma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	non-Hodgkins lymphoma	DNA topoisomerase II alpha inhibitor	4.0	-	DailyMed
DOXORUBICIN	Small molecule	Fallopian Tube Carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	Mantle cell lymphoma	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	lung cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	1.0	Withdrawn	ClinicalTrials
MITOXANTRONE	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
BECATECARIN	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	rhabdomyosarcoma	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE PHOSPHATE	Small molecule	medulloblastoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
MITOXANTRONE	Small molecule	myeloproliferative disorder	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
VALRUBICIN	Small molecule	urothelial carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	liver cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	endometrial cancer	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	2.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	multiple myeloma	DNA topoisomerase II alpha inhibitor	3.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	brain neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	breast cancer	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	classic Hodgkin lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	T-lymphoblastic lymphoma	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
DOXORUBICIN	Small molecule	malignant glioma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute myelomonocytic leukemia	DNA topoisomerase II inhibitor	3.0	Completed	ClinicalTrials
IDARUBICIN	Small molecule	acute promyelocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	diffuse large B-cell lymphoma	DNA topoisomerase II alpha inhibitor	1.0	Completed	ClinicalTrials
DAUNORUBICIN	Small molecule	leukemia	DNA topoisomerase II alpha inhibitor	3.0	Withdrawn	ClinicalTrials
ETOPOSIDE	Small molecule	neuroblastoma	DNA topoisomerase II inhibitor	1.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	sarcoma	DNA topoisomerase II alpha inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	multiple myeloma	DNA topoisomerase II inhibitor	2.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	anaplastic astrocytoma	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian neoplasm	DNA topoisomerase II alpha inhibitor	4.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	head and neck malignant neoplasia	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	metastasis	DNA topoisomerase II alpha inhibitor	1.0	Terminated	ClinicalTrials
DOXORUBICIN	Small molecule	urinary bladder cancer	DNA topoisomerase II alpha inhibitor	3.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	peritoneum cancer	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	ovarian cancer	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	extraskeletal myxoid chondrosarcoma	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
ETOPOSIDE	Small molecule	digestive system neuroendocrine neoplasm	DNA topoisomerase II inhibitor	2.0	Recruiting	ClinicalTrials
DOXORUBICIN	Small molecule	metastatic malignant neoplasm	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	gastric carcinoma	DNA topoisomerase II alpha inhibitor	1.0	Recruiting	ClinicalTrials
DEXRAZOXANE	Small molecule	myelodysplastic syndrome	DNA topoisomerase II inhibitor	2.0	Active, not recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Unknown status	ClinicalTrials
ETOPOSIDE	Small molecule	acute lymphoblastic leukemia	DNA topoisomerase II inhibitor	2.0	Withdrawn	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
IDARUBICIN	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	3.0	Unknown status	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	acute myeloid leukemia	DNA topoisomerase II alpha inhibitor	2.0	Not yet recruiting	ClinicalTrials
MITOXANTRONE HYDROCHLORIDE	Small molecule	lymphoma	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	non-small cell lung carcinoma	DNA topoisomerase II inhibitor	1.0	Active, not recruiting	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	inflammatory breast carcinoma	DNA topoisomerase II alpha inhibitor	2.0	Completed	ClinicalTrials
DAUNORUBICIN HYDROCHLORIDE	Small molecule	chronic myelomonocytic leukemia	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN HYDROCHLORIDE	Small molecule	endometrial endometrioid adenocarcinoma, variant with squamous differentiation	DNA topoisomerase II alpha inhibitor	3.0	Completed	ClinicalTrials
DOXORUBICIN	Small molecule	fallopian tube cancer	DNA topoisomerase II alpha inhibitor	2.0	Terminated	ClinicalTrials
ETOPOSIDE	Small molecule	hemophagocytic syndrome	DNA topoisomerase II inhibitor	3.0	Recruiting	ClinicalTrials
IDARUBICIN HYDROCHLORIDE	Small molecule	therapy related acute myeloid leukemia and myelodysplastic syndrome	DNA topoisomerase II alpha inhibitor	2.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	extranodal nasal NK/T cell lymphoma	DNA topoisomerase II inhibitor	4.0	Unknown status	ClinicalTrials
DOXORUBICIN	Small molecule	renal pelvis/ureter urothelial carcinoma	DNA topoisomerase II alpha inhibitor	3.0	Recruiting	ClinicalTrials
ETOPOSIDE	Small molecule	hematopoietic and lymphoid cell neoplasm	DNA topoisomerase II inhibitor	1.0	Withdrawn	ClinicalTrials
BERUBICIN	Small molecule	malignant glioma	DNA topoisomerase II inhibitor	1.0	Not yet recruiting	ClinicalTrials

Welcome to

RBP World!

Drugs target to TOP2A

Targets details